NCT02033551View on ClinicalTrials.gov

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Breast CancerOvarian CancerColon CancerLung CancerGastric CancerSolid Tumors
Interventions
DRUG

Veliparib

DRUG

Carboplatin

DRUG

Paclitaxel

DRUG

FOLFIRI

combination of Fluorouracil, leucovorin and irinotecan

Trial Locations (5)

28050

Site Reference ID/Investigator# 117451, Madrid

78229

Site Reference ID/Investigator# 117415, San Antonio

85258

Site Reference ID/Investigator# 117416, Scottsdale

9713 GZ

Site Reference ID/Investigator# 117337, Groningen

6229 HX

Site Reference ID/Investigator# 117338, Maastricht

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY